Fidelity SPDR Advertisement
Home > Boards > US Listed > Medical - Drugs >

RXI Pharmaceuticals Corp (RXII)

RXII RSS Feed
Add RXII Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator now invest, zoriden, Inoviorulez
Search This Board:
Last Post: 9/19/2014 9:58:28 PM - Followers: 78 - Board type: Free - Posts Today: 0

About RXi Pharmaceuticals

RXi Pharmaceuticals Corporation (OTC: RXII) is a biotechnology company focused on discovering, developing and commercializing innovative therapies based on its proprietary, next-generation RNAi platform.  Therapeutics that use RNA interference, or "RNAi," have great promise because of their ability to "silence," or down-regulate, the expression of a specific gene that may be overexpressed in a disease condition.  Building on the pioneering work of scientific founder and Nobel Laureate Dr. Craig Mello, RXi's first RNAi product candidate, RXI-109, entered into RXi's first human clinical trial in 2012.  RXI-109 targets connective tissue growth factor (CTGF), a key regulatory of fibrosis and scar formation, and is initially being developed to reduce or inhibit scar formation in the skin following surgery.



RXi Pharmaceuticals Corp., has received patent approval for their new experimental breast cancer vaccine which became part of the company's arsenal after acquiring Apthera Inc. in April of this year.
The specific patents in question regard using the vaccine NeuVax with the drug Herceptin which is used in women to slow the production of the HER2 protein in tumors, while NeuVax attempts to make the body's immune system fight off cancerous cells.
According to The Telegram:
"The patents also cover using NeuVax in patients not eligible for Herceptin treatment."
With their patent in place the company plans to begin human tests in early 2012.
According to RXi the patents were developed by Dr. George E. Peoples, director of the Cancer Vaccine Development Program for the U.S. Military Cancer Institute and RXi is leasing the patents for their own work.




This May, RXi Pharmaceuticals Corp. observed two momentous events: The biotechnology company completed its spinoff from Galena Biopharma Inc., and Dr. Geert Cauwenbergh took the helm as president and chief executive officer. The small company's first product, an anti-scarring medication called RXI-109, entered clinical trials this year, and is based on the pioneering work in RNA interference of RXi scientific founder and Nobel Laureate Dr. Craig C. Mello. Dr. Cauwenbergh came to RXi after a long career in pharmaceuticals, most recently as president and chief executive officer of a company he founded, Barrier Therapeutics. What attracted you to come to Worcester? "It was the technology, well, the technology and the chemistry with these people. They're very bright." As a publicly traded company, how do you reconcile the needs of the investors, which are sometimes a short-term desire for profits, with the needs of medical research, which sometimes takes years? "Through business development. Basically what you do as a small biotech is you try to create a big network with people who have interest in various stages of development. ... In two or three years they get antsy and they want to cash in, but at that point in time there will be and there is already a network of business development contacts in place where you can for instance get nondiluted money without having to raise money and go back to the stock market and shareholders by making regional deals or geographic deals ...

Press Releases
RXi Pharmaceuticals to Present at Biotech Showcase™ 2013 - December 19, 2012
RXi Pharmaceuticals Announces Initiation of Second Double-Blind Vehicle Controlled Phase 1 Study With Its Anti-Scarring Compound, RXI-109 - December 5, 2012
RXi Pharmaceuticals Announces Pharmacokinetic Results of its Single Dose Phase 1 Study with RXI-109 in Healthy Volunteers - November 15, 2012
RXi Pharmaceuticals Reports Financial Results for the Third Quarter of 2012 - November 14, 2012
RXi Pharmaceuticals to Present at 12th Annual Biotech Symposium - October 16, 2012
RXi Pharmaceuticals Awarded NCI SBIR Funding to Advance Self-Delivering RNAi Technology - October 4, 2012
RXi Pharmaceuticals to Present at 11th Annual BIO Investor Forum - October 2, 2012
RXi Pharmaceuticals Announces Completion of Dosing in Phase 1 Trial for RXI-109 Program - September 24, 2012
RXi Pharmaceuticals Reports Financial Results for the Second Quarter of 2012 - August 15, 2012
RXi Pharmaceuticals Appoints Jeannette Graf MD and Leroy Young MD to its Scientific Advisory Board - July 13, 2012
 

Share Statistics
Avg Vol (3 month)3: 215,443
Avg Vol (10 day)3: 145,371
Shares Outstanding5: 338m
Float: 53.34M
% Held by Insiders1: 9.01%
% Held by Institutions1: 0.50%
 



http://www.rxipharma.com/

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
RXII
Current Price
Volume:
Bid Ask Day's Range
Wiki
RXII News: RXi Pharmaceuticals Presented an Update on the Company's Dermatology and Ophthalmology Franchises 09/11/2014 07:02:00 AM
RXII News: RXi Pharmaceuticals to Present at the Rodman & Renshaw 16th Annual Global Investment Conference 09/03/2014 07:02:00 AM
RXII News: RXi Pharmaceuticals Reports Financial Results for the Second Quarter of 2014 08/14/2014 07:05:00 AM
RXII News: RXi Pharmaceuticals Celebrates Expansion of its Operations in Massachusetts 07/02/2014 07:02:00 AM
RXII News: RXi Pharmaceuticals Set to Join Russell Microcap Index 06/25/2014 07:02:00 AM
PostSubject
#1546  Sticky Note New Seeking Alpha article. http://m.seekingalpha.com/article/2502925-after-a-40- Titan V 09/17/14 08:26:56 PM
#1557   If you are invested for the long term Titan V 09/19/14 09:58:28 PM
#1556   Buy for the loooooong term. dawson-m 09/19/14 01:47:21 PM
#1555   In with a starter position of 10k shares value1008 09/19/14 11:42:45 AM
#1554   RXi Pharmaceuticals to Present at the 7th Annual tomsylver 09/18/14 11:45:42 PM
#1553   undiscovered gem IMO> you should have been here Inoviorulez 09/18/14 09:59:44 PM
#1552   This stock is 5 times more than many JDUser1963 09/18/14 08:39:34 PM
#1551   Next presentation though is important. It's a partnering Inoviorulez 09/18/14 06:10:06 PM
#1550   AS RXII keeps scheduling these presentations... more and now invest 09/18/14 12:26:46 PM
#1549   Seems that everytime it starts to pull back now invest 09/18/14 12:25:58 PM
#1548   Looks like people like that Motley fool article... now invest 09/18/14 12:24:47 PM
#1547   Ah... stock is seeing some buying that is good... now invest 09/18/14 12:24:07 PM
#1546   New Seeking Alpha article. http://m.seekingalpha.com/article/2502925-after-a-40- Titan V 09/17/14 08:26:56 PM
#1545   7:05 am RXi Pharma granted a patent by tomsylver 09/17/14 11:12:31 AM
#1544   why, the day's end? dawson-m 09/17/14 08:32:03 AM
#1543   So again to view greatness of this company 1 million 09/17/14 08:13:49 AM
#1542   Insider CAUWENBERGH bought 10.000 shares @ 2.18-2.19 on HHHG 09/16/14 03:02:33 PM
#1541   Seems like MM's are playing games right now, JDUser1963 09/15/14 09:26:01 PM
#1540   Good article explaining the results for those confused BiotehPickList 09/14/14 10:46:06 PM
#1539   I know this is late responding to your david29 09/14/14 03:02:46 PM
#1537   one picture from RXI-109multi-dose Phase 1 clinical trial wildbullus 09/14/14 08:22:27 AM
#1536   Pretty much sums it up. Those investors that Inoviorulez 09/12/14 05:58:07 PM
#1535   So what now,where might this companies stock entail 1 million 09/12/14 08:32:08 AM
#1534   Those moron pumpers on Stock twits saying when zoriden 09/11/14 05:10:42 PM
#1533   I guess the big run did its thing,now 1 million 09/11/14 03:57:52 PM
#1532   New article on SA. http://m.seekingalpha.com/article/2487515-update-rxi-pharmace Titan V 09/11/14 09:46:59 AM
#1531   RED ALL PREMARKET STOCKS sedrik 09/11/14 09:05:15 AM
#1530   new update by company " RXi Pharmaceuticals Presented Inoviorulez 09/11/14 07:18:14 AM
#1529   I agree with you. My analysis after examining Inoviorulez 09/10/14 08:26:59 PM
#1528   The stock was recently infiltrated by day traders readthechinastudy 09/10/14 04:58:14 PM
#1527   Some group of money knows something,always @ the 1 million 09/10/14 01:49:08 PM
#1526   I got some around there too, put a Kalinn 09/10/14 01:10:15 PM
#1525   I hope so. <shaking head in disbelief>. To readthechinastudy 09/10/14 12:56:18 PM
#1524   Market Mover bear raid. Going to bounce. willlbone 09/10/14 12:26:38 PM
#1523   Not sure, but I cashed out at 3.54. Natetex 09/10/14 12:08:12 PM
#1522   What happened here? Huge drop at noon. willlbone 09/10/14 12:05:46 PM
#1520   I would guess pre-market tomorrow. I would hate zoriden 09/09/14 07:12:07 AM
#1519   RXII pps is up 60% from the intra-day pistol1p 09/09/14 01:59:57 AM
#1518   Agreed. The weekly chart shows this is near readthechinastudy 09/08/14 11:32:21 PM
#1517   I concur. This is a significantly undervalued company Canoepaddler 09/08/14 09:40:52 PM
#1516   RXII results should be good, because I don't Inoviorulez 09/08/14 08:00:52 PM
#1515   Hey.. the stock is moving up.... and now invest 09/08/14 07:33:11 PM
#1514   this should be interesting. I'm all in david29 09/08/14 11:23:30 AM
#1513   This is the hottest biotech over at StockTwits Titan V 09/07/14 10:33:34 PM
#1512   David it has been like this for 2 zoriden 09/07/14 08:00:08 PM
#1511   what is up with this board? are david29 09/07/14 07:37:19 PM
#1510   Yeah I think we will be fine safety zoriden 09/07/14 06:40:42 PM
#1509   Tian V, I heard that they use two wildbullus 09/07/14 03:06:18 PM
#1508   That must have sucked for the shareholders. I Titan V 09/07/14 02:24:20 PM
#1507   I am with you, I also think the wildbullus 09/07/14 10:22:25 AM
#1506   They should have had data for some time, Titan V 09/06/14 10:37:43 PM
PostSubject